Related Experiment Videos

Ca(2+)-channels and adrenoceptors in diabetic skeletal muscle

S L Lee1, N S Dhalla

  • 1Division of Cardiovascular Sciences, St. Boniface General Hospital Research Centre, University of Manitoba, Winnipeg, Canada.

Insights

Diabetic rat muscle shows increased calcium (Ca2+) channels and beta-adrenoceptors, but not alpha-adrenoceptors. This suggests altered ion channel and receptor activity contributes to diabetic muscle hyperfunction.

Area of Science:

  • Biochemistry
  • Physiology
  • Endocrinology

Background:

  • Diabetes mellitus is a metabolic disorder with significant complications affecting various tissues.
  • Skeletal muscle function is crucial for overall health and can be impaired in diabetic conditions.
  • Understanding molecular changes in diabetic muscle is key to addressing associated complications.

Purpose of the Study:

  • To investigate alterations in calcium (Ca2+) channels and adrenoceptors in skeletal muscle of diabetic rats.
  • To determine if changes in receptor density or affinity occur in response to diabetes.
  • To explore the potential link between these molecular changes and muscle hyperfunction in diabetes.

Main Methods:

  • Induction of diabetes in rats using streptozotocin injection.
  • Scatchard plot analysis to quantify receptor binding.
  • Radioligand binding assays using 3H-nitrendipine (for Ca2+ channels), 3H-dihydroalprenolol (for beta-adrenoceptors), and 3H-prazosin (for alpha-adrenoceptors).

Main Results:

  • Diabetic rat skeletal muscle exhibited a significant increase in the density of Ca2+ channels.
  • A notable increase in beta-adrenoceptor density was observed in diabetic muscle.
  • No significant changes in the density or affinity of alpha-adrenoceptors were detected.

Conclusions:

  • Diabetes induces specific increases in Ca2+ channel and beta-adrenoceptor density in skeletal muscle.
  • These molecular alterations may contribute to the observed hyperfunction of diabetic skeletal muscle.
  • The findings highlight potential targets for managing diabetic muscle complications.

Related Concept Videos